|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
84,540,000 |
Market
Cap: |
346.61(M) |
Last
Volume: |
34,905,322 |
Avg
Vol: |
12,600,109 |
52
Week Range: |
$4.1 - $4.1 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Maddon Paul J |
Chief Executive Officer/CSO |
|
2010-12-01 |
4 |
AB |
$4.90 |
$24,500 |
D/D |
5,000 |
854,057 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2010-11-01 |
4 |
AB |
$4.76 |
$23,800 |
D/D |
5,000 |
849,057 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2010-10-04 |
4 |
AB |
$4.99 |
$24,950 |
D/D |
5,000 |
844,057 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-10-01 |
4 |
D |
$5.08 |
$40,361 |
D/D |
(7,945) |
42,851 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-10-01 |
4 |
OE |
$4.32 |
$37,938 |
D/D |
8,786 |
50,796 |
|
- |
|
Baker Mark Robert |
President |
|
2010-10-01 |
4 |
D |
$5.08 |
$81,138 |
D/D |
(15,972) |
29,186 |
|
- |
|
Baker Mark Robert |
President |
|
2010-10-01 |
4 |
OE |
$4.32 |
$75,759 |
D/D |
17,545 |
45,158 |
|
- |
|
Olson William C |
SR. VP, Research & Development |
|
2010-10-01 |
4 |
D |
$5.08 |
$31,770 |
D/D |
(6,254) |
46,871 |
|
- |
|
Olson William C |
SR. VP, Research & Development |
|
2010-10-01 |
4 |
OE |
$4.32 |
$29,859 |
D/D |
6,915 |
53,125 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2010-10-01 |
4 |
D |
$5.08 |
$37,805 |
D/D |
(7,442) |
44,442 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2010-10-01 |
4 |
OE |
$4.32 |
$35,533 |
D/D |
8,229 |
51,884 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2010-09-01 |
4 |
AB |
$4.10 |
$20,500 |
D/D |
5,000 |
839,057 |
|
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2010-08-02 |
4 |
B |
$4.75 |
$23,750 |
D/D |
5,000 |
834,057 |
2.81 |
- |
|
Maddon Paul J |
Chief Executive Officer/CSO |
|
2010-07-16 |
4 |
AB |
$4.98 |
$24,950 |
D/D |
5,000 |
829,057 |
|
- |
|
Baker Mark Robert |
President |
|
2010-07-01 |
4 |
D |
$5.35 |
$21,978 |
D/D |
(4,108) |
27,395 |
|
- |
|
Baker Mark Robert |
President |
|
2010-07-01 |
4 |
OE |
$4.44 |
$20,313 |
D/D |
4,575 |
31,503 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
41,792 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-07-01 |
4 |
D |
$5.35 |
$17,243 |
D/D |
(3,223) |
31,792 |
|
- |
|
Israel Robert J |
Sr. VP, Medical Affairs |
|
2010-07-01 |
4 |
OE |
$4.44 |
$15,940 |
D/D |
3,590 |
35,015 |
|
- |
|
Olson William C |
SR. VP, Research & Development |
|
2010-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
45,992 |
|
- |
|
Olson William C |
SR. VP, Research & Development |
|
2010-07-01 |
4 |
D |
$5.35 |
$12,209 |
D/D |
(2,282) |
35,992 |
|
- |
|
Olson William C |
SR. VP, Research & Development |
|
2010-07-01 |
4 |
OE |
$4.44 |
$11,282 |
D/D |
2,541 |
38,274 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2010-07-01 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
43,437 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2010-07-01 |
4 |
D |
$5.35 |
$12,851 |
D/D |
(2,402) |
33,437 |
|
- |
|
Mckinney Robert A |
Chief Financial Officer |
|
2010-07-01 |
4 |
OE |
$4.44 |
$11,877 |
D/D |
2,675 |
35,839 |
|
- |
|
801 Records found
|
|
Page 7 of 33 |
|
|